EQ
Equillium, Inc.
Company overview
- Market capitalization
- $106.53M
- Employees
- 14
- Latest publication
- 2026-09-29
About Equillium, Inc.
Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States. The company develops EQ504, a novel AhR modulator that is in preclinical-stage for the treatment of ulcerative colitis and lung inflammation diseases. It also develops EQ302, a bi-specific inhibitor of IL-15 and IL-21 formulated for oral delivery for the treatment of celiac diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 4,392,000USD | 12,161,000USD | 13,853,000USD |
| Cost Of Revenue | 24,000USD | 23,000USD | 28,000USD | 32,000USD | 33,000USD | 35,000USD | 35,000USD | 35,000USD |
| Gross Profit | -24,000USD | -23,000USD | -28,000USD | -32,000USD | -33,000USD | 4,392,000USD | 12,161,000USD | 13,853,000USD |
| Research Development | 2,991,000USD | 1,536,000USD | 1,301,000USD | 4,083,000USD | 5,924,000USD | 7,315,000USD | 9,562,000USD | 10,808,000USD |
| Selling General Administrative | 2,619,000USD | 2,426,000USD | 3,274,000USD | 2,145,000USD | 2,946,000USD | 1,775,000USD | 3,278,000USD | 3,145,000USD |
| Total Operating Expenses | 5,586,000USD | 3,939,000USD | 4,575,000USD | 6,196,000USD | 8,870,000USD | 9,090,000USD | 12,840,000USD | 13,953,000USD |
| Operating Income | -5,610,000USD | -3,962,000USD | -4,575,000USD | -6,228,000USD | -8,870,000USD | -4,698,000USD | -679,000USD | -100,000USD |
| Interest Income | 309,000USD | 303,000USD | 235,000USD | 122,000USD | 173,000USD | 239,000USD | 331,000USD | 371,000USD |
| Net Interest Income | 309,000USD | 303,000USD | 235,000USD | 122,000USD | 173,000USD | 239,000USD | 331,000USD | 371,000USD |
| Income Before Tax | -5,311,000USD | -3,775,000USD | -4,230,000USD | -5,739,000USD | -8,654,000USD | -5,433,000USD | -7,000USD | 468,000USD |
| Net Income | -5,311,000USD | -3,775,000USD | -4,230,000USD | -5,739,000USD | -8,654,000USD | -5,794,000USD | -7,000USD | 468,000USD |
| Net Income From Continuing Ops | -5,311,000USD | -3,775,000USD | -4,230,000USD | -5,739,000USD | -8,654,000USD | -5,794,000USD | -7,000USD | 468,000USD |
| Ebit | -5,610,000USD | -3,962,000USD | -4,575,000USD | -6,228,000USD | -8,870,000USD | -5,433,000USD | -7,000USD | -100,000USD |
| Ebitda | -5,586,000USD | -3,939,000USD | -4,547,000USD | -6,196,000USD | -8,837,000USD | -5,398,000USD | 28,000USD | -65,000USD |
| Depreciation And Amortization | 24,000USD | 23,000USD | 28,000USD | 32,000USD | 33,000USD | 35,000USD | 35,000USD | 35,000USD |
| Reconciled Depreciation | 24,000USD | 23,000USD | 28,000USD | 32,000USD | 33,000USD | 35,000USD | 35,000USD | 35,000USD |
| Total Other Income Expense Net | 299,000USD | 187,000USD | 345,000USD | 489,000USD | 216,000USD | -735,000USD | 672,000USD | 568,000USD |
| Interest Expense | — | — | — | — | — | 0USD | 0USD | 0USD |
| Income Tax Expense | — | — | — | — | — | 361,000USD | — | — |
| Tax Provision | — | — | — | — | — | 361,000USD | 0USD | 0USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 35,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 130,000USD | 41,095,000USD | 36,084,000USD | 15,759,000USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 116,000USD | 137,000USD | 126,000USD | 118,000USD | 72,000USD | 45,000USD | 23,000USD | 6,102USD |
| Gross Profit | -116,000USD | 41,095,000USD | 36,084,000USD | 15,759,000USD | -72,000USD | -45,000USD | -23,000USD | -6,102USD |
| Research Development | 12,843,000USD | 37,428,000USD | 37,039,000USD | 37,547,000USD | 26,379,000USD | 19,384,000USD | 17,640,000USD | 4,943,000USD |
| Selling General Administrative | 10,791,000USD | 11,936,000USD | 13,567,000USD | 17,239,000USD | 11,407,000USD | 10,164,000USD | 9,087,000USD | 3,672,000USD |
| Total Operating Expenses | 23,634,000USD | 49,364,000USD | 50,606,000USD | 77,835,000USD | 37,786,000USD | 29,548,000USD | 26,727,000USD | 8,615,000USD |
| Operating Income | -23,634,000USD | -8,269,000USD | -14,522,000USD | -62,076,000USD | -37,786,000USD | -29,548,000USD | -26,727,000USD | -8,615,000USD |
| Interest Income | 833,000USD | 1,381,000USD | 2,018,000USD | 420,000USD | 57,000USD | 476,000USD | 1,391,000USD | 339,620USD |
| Net Interest Income | 833,000USD | 1,381,000USD | 1,256,000USD | -633,000USD | -1,016,000USD | -623,000USD | 1,112,000USD | -2,217,890USD |
| Income Before Tax | -22,398,000USD | -7,706,000USD | -12,755,000USD | -62,428,000USD | -39,052,000USD | -29,813,000USD | -25,600,000USD | -13,250,000USD |
| Tax Provision | 0USD | 361,000USD | 580,000USD | 0USD | — | — | — | — |
| Net Income | -22,398,000USD | -8,067,000USD | -13,335,000USD | -62,428,000USD | -38,980,000USD | -29,768,000USD | -25,577,000USD | -13,250,000USD |
| Net Income From Continuing Ops | -22,398,000USD | -8,067,000USD | -8,220,000USD | -62,428,000USD | -39,111,000USD | -29,813,000USD | -25,600,000USD | -13,250,475USD |
| Ebit | -23,634,000USD | -7,706,000USD | -12,264,000USD | -61,375,000USD | -37,786,000USD | -29,548,000USD | -26,727,000USD | -8,615,000USD |
| Ebitda | -23,518,000USD | -7,569,000USD | -12,138,000USD | -61,257,000USD | -37,714,000USD | -29,503,000USD | -26,704,000USD | -8,608,898USD |
| Depreciation And Amortization | 116,000USD | 137,000USD | 126,000USD | 118,000USD | 72,000USD | 45,000USD | 23,000USD | 6,102USD |
| Reconciled Depreciation | 116,000USD | 137,000USD | 125,000USD | 118,000USD | 72,000USD | 45,000USD | 23,000USD | 6,102USD |
| Total Other Income Expense Net | 1,236,000USD | 563,000USD | 1,767,000USD | -352,000USD | -1,266,000USD | -265,000USD | 1,127,000USD | -4,635,000USD |
| Interest Expense | — | 0USD | 491,000USD | 1,053,000USD | 1,073,000USD | 1,099,000USD | 279,000USD | 2,557,510USD |
| Income Tax Expense | — | 361,000USD | 580,000USD | 45,279,000USD | -72,000USD | -45,000USD | -23,000USD | 140,512USD |
| Selling And Marketing Expenses | — | — | 126,000USD | — | — | — | — | — |
| Unclassified Operating Expenses | — | — | — | 23,049,000USD | — | — | — | — |
| Net Income Applicable To Common Shares | — | — | — | -62,428,000USD | -39,052,000USD | -29,813,000USD | -25,600,000USD | -13,250,000USD |
| Non Operating Income Net Other | — | — | — | — | -252,000USD | 793,000USD | 1,450,000USD | -2,072,099USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 58,666,000USD | 63,083,000USD | 31,887,000USD | 34,506,000USD | 12,399,000USD | 16,729,000USD | 25,604,000USD | 34,457,000USD |
| Cash And Equivalents | 57,164,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 57,976,000USD | 62,275,000USD | 30,277,000USD | 33,579,000USD | 11,952,000USD | 16,216,000USD | 24,978,000USD | 33,646,000USD |
| Other Current Assets | 812,000USD | 953,000USD | -108,000USD | 459,000USD | 422,000USD | 669,000USD | 1,259,000USD | 1,564,000USD |
| Other Non Current Assets | 27,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 2,650,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 2,478,000USD | 3,345,000USD | 2,934,000USD | 3,094,000USD | 7,234,000USD | 6,002,000USD | 6,356,000USD | 11,057,000USD |
| Other Current Liabilities | 1,216,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 56,016,000USD | 59,487,000USD | 28,597,000USD | 30,939,000USD | 5,056,000USD | 10,578,000USD | 19,061,000USD | 23,177,000USD |
| Total Equity Including Noncontrolling Interest | 56,016,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 663,000USD | 781,000USD | 658,000USD | 927,000USD | 447,000USD | 513,000USD | 626,000USD | 766,000USD |
| Accounts Payable | 850,000USD | 1,295,000USD | 755,000USD | 1,082,000USD | 4,812,000USD | 3,058,000USD | 2,676,000USD | 3,666,000USD |
| Short Term Debt | 412,000USD | 441,000USD | 363,000USD | 272,000USD | 150,000USD | 146,000USD | 197,000USD | 274,000USD |
| Common Stock | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD |
| Retained Earnings | -226,209,000USD | -221,516,000USD | -216,205,000USD | -212,430,000USD | -208,200,000USD | -202,461,000USD | -193,807,000USD | -188,013,000USD |
| Accumulated Other Comprehensive Income | 381,000USD | 370,000USD | 363,000USD | 270,000USD | 385,000USD | 731,000USD | 781,000USD | -3,000USD |
| Total Liab | — | 3,596,000USD | 3,290,000USD | 3,567,000USD | 7,343,000USD | 6,151,000USD | 6,543,000USD | 11,280,000USD |
| Other Current Liab | — | 1,609,000USD | 1,816,000USD | 1,740,000USD | 2,255,000USD | 2,433,000USD | 3,118,000USD | 5,049,000USD |
| Capital Stock | — | 5,000USD | 5,000USD | 5,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD |
| Cash | — | 61,322,000USD | 30,277,000USD | 33,120,000USD | 11,495,000USD | 14,502,000USD | 18,085,000USD | 15,448,000USD |
| Cash And Short Term Investments | — | 61,322,000USD | 30,277,000USD | 33,120,000USD | 11,495,000USD | 14,502,000USD | 22,575,000USD | 25,877,000USD |
| Net Debt | — | -60,630,000USD | -29,558,000USD | -32,375,000USD | -11,236,000USD | -14,207,000USD | -17,701,000USD | -14,951,000USD |
| Short Long Term Debt Total | — | 692,000USD | 719,000USD | 745,000USD | 259,000USD | 295,000USD | 384,000USD | 497,000USD |
| Property Plant Equipment Gross | — | 781,000USD | 1,384,000USD | 927,000USD | 447,000USD | 513,000USD | 1,125,000USD | 766,000USD |
| Common Stock Shares Outstanding | — | 96,279,216shares | 91,881,058shares | 35,719,317shares | 35,719,317shares | 35,586,861shares | 35,357,641shares | 35,424,388shares |
| Non Current Assets Total | — | 808,000USD | 658,000USD | 927,000USD | 447,000USD | 513,000USD | 626,000USD | 811,000USD |
| Non Current Liabilities Total | — | 251,000USD | 356,000USD | 473,000USD | 109,000USD | 149,000USD | 187,000USD | 222,999USD |
| Non Currrent Assets Other | — | 27,000USD | 27,000USD | — | — | — | — | 45,000USD |
| Net Working Capital | — | 58,930,000USD | 28,104,000USD | 30,485,000USD | 4,718,000USD | 10,214,000USD | 18,622,000USD | 22,589,000USD |
| Unclassified Equity | — | 280,623,000USD | 244,429,000USD | 243,089,000USD | 212,865,000USD | 212,302,000USD | 212,081,000USD | 211,187,000USD |
| Other Assets | — | — | 952,000USD | — | — | — | — | — |
| Short Term Investments | — | — | 0USD | 0USD | 0USD | 0USD | 4,490,000USD | 10,429,000USD |
| Net Receivables | — | — | 108,000USD | — | 35,000USD | 1,045,000USD | 1,144,000USD | 6,205,000USD |
| Current Deferred Revenue | — | — | — | — | — | — | — | 2,068,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 31,887,000USD | 25,604,000USD | 50,530,000USD | 78,421,000USD | 85,405,000USD | 85,428,000USD | 55,539,000USD | 67,163,000USD |
| Other Current Assets | -108,000USD | 1,259,000USD | 2,197,000USD | 1,599,000USD | 3,049,000USD | 3,265,000USD | 2,288,000USD | 1,186,000USD |
| Total Liab | 3,290,000USD | 6,543,000USD | 27,957,000USD | 46,479,000USD | 18,900,000USD | 15,574,000USD | 13,691,000USD | 2,228,000USD |
| Total Stockholder Equity | 28,597,000USD | 19,061,000USD | 22,573,000USD | 31,942,000USD | 66,505,000USD | 69,854,000USD | 41,848,000USD | 64,935,000USD |
| Other Current Liab | 1,816,000USD | 3,118,000USD | 6,697,000USD | 7,239,000USD | 5,886,000USD | 2,813,000USD | 2,010,000USD | 909,000USD |
| Common Stock | 5,000USD | 3,000USD | 3,000USD | 3,000USD | 2,000USD | 2,000USD | 1,000USD | 789USD |
| Capital Stock | 5,000USD | 3,000USD | 3,000USD | 3,000USD | 2,000USD | 2,000USD | 1,000USD | 789USD |
| Retained Earnings | -216,205,000USD | -193,807,000USD | -185,740,000USD | -172,405,000USD | -109,977,000USD | -70,925,000USD | -41,112,000USD | -15,512,349USD |
| Other Assets | 952,000USD | — | 1USD | 3,369,000USD | 153,000USD | -254,000USD | -108,000USD | -63,515USD |
| Cash | 30,277,000USD | 18,085,000USD | 23,216,000USD | 59,107,000USD | 50,366,000USD | 23,982,000USD | 13,219,000USD | 28,508,534USD |
| Cash And Short Term Investments | 30,277,000USD | 22,575,000USD | 40,866,000USD | 71,023,000USD | 80,711,000USD | 82,163,000USD | 53,143,000USD | 65,913,000USD |
| Total Current Assets | 30,277,000USD | 24,978,000USD | 49,349,000USD | 76,735,000USD | 83,760,000USD | 85,428,000USD | 55,539,000USD | 67,163,000USD |
| Total Current Liabilities | 2,934,000USD | 6,356,000USD | 27,573,000USD | 32,038,000USD | 8,915,000USD | 7,245,000USD | 3,883,000USD | 2,028,000USD |
| Net Debt | -29,558,000USD | -17,701,000USD | -22,392,000USD | -48,922,000USD | -40,381,000USD | -15,707,000USD | -3,538,000USD | -28,308,534USD |
| Short Term Debt | 363,000USD | 197,000USD | 440,000USD | 6,122,000USD | 1,804,000USD | 1,666,000USD | — | — |
| Short Long Term Debt Total | 719,000USD | 384,000USD | 824,000USD | 10,185,000USD | 10,554,000USD | 9,941,000USD | 9,681,000USD | 200,000USD |
| Short Term Investments | 0USD | 4,490,000USD | 17,650,000USD | 11,916,000USD | 30,345,000USD | 58,181,000USD | 39,924,000USD | 37,404,750USD |
| Net Receivables | 108,000USD | 1,144,000USD | 6,286,000USD | 4,113,000USD | 0USD | — | — | — |
| Accounts Payable | 755,000USD | 2,676,000USD | 4,707,000USD | 3,977,000USD | 1,225,000USD | 2,766,000USD | 1,873,000USD | 1,119,000USD |
| Property Plant Equipment Net | 658,000USD | 626,000USD | 1,111,000USD | 1,582,000USD | 1,645,000USD | 239,000USD | 93,000USD | 63,515USD |
| Property Plant Equipment Gross | 1,384,000USD | 1,125,000USD | 1,475,000USD | 1,191,000USD | 1,645,000USD | 239,000USD | 93,000USD | 63,515USD |
| Accumulated Other Comprehensive Income | 363,000USD | 781,000USD | 140,000USD | 76,000USD | -138,000USD | -297,000USD | 21,000USD | 5,279USD |
| Common Stock Shares Outstanding | 91,881,058shares | 35,357,641shares | 34,726,384shares | 33,727,945shares | 28,806,310shares | 20,355,534shares | 17,378,096shares | 12,190,245shares |
| Non Current Assets Total | 658,000USD | 626,000USD | 1,181,000USD | 1,686,000USD | 1,645,000USD | 254,000USD | 108,000USD | 63,515USD |
| Non Current Liabilities Total | 356,000USD | 187,000USD | 384,000USD | 14,441,000USD | 9,985,000USD | 8,329,000USD | 9,808,000USD | 200,000USD |
| Non Currrent Assets Other | 27,000USD | — | 70,000USD | 104,000USD | 153,000USD | -239,000USD | -93,000USD | 63,515USD |
| Net Working Capital | 28,104,000USD | 18,622,000USD | 21,776,000USD | 44,697,000USD | 74,845,000USD | 77,929,000USD | 51,548,000USD | 65,071,151USD |
| Unclassified Equity | 244,429,000USD | 212,081,000USD | 208,167,000USD | 204,265,000USD | 176,616,000USD | 141,072,000USD | 82,937,000USD | 80,440,492USD |
| Current Deferred Revenue | — | — | 15,729,000USD | 14,700,000USD | — | — | — | — |
| Other Liab | — | — | — | 10,378,000USD | — | 54,000USD | 127,000USD | 200,000USD |
| Short Long Term Debt | — | — | — | 5,714,000USD | 1,428,000USD | 1,666,000USD | — | — |
| Long Term Debt | — | — | — | 3,239,000USD | 8,750,000USD | 8,275,000USD | 9,681,000USD | 200,000USD |
| Non Current Liabilities Other | — | — | — | 4,063,000USD | 1,235,000USD | 54,000USD | 127,000USD | 199,530USD |
| Net Tangible Assets | — | — | — | 31,942,000USD | 66,505,000USD | 69,854,000USD | 41,848,000USD | 64,935,000USD |
| Unclassified Non Current Assets | — | — | — | -3,369,000USD | — | — | — | — |
| Unclassified Current Liabilities | — | — | — | -5,714,000USD | -1,428,000USD | -1,666,000USD | — | — |
| Unclassified Non Current Liabilities | — | — | — | -3,239,000USD | — | — | — | — |
| Intangible Assets | — | — | — | — | — | — | 38,000USD | 22,770USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 50,000USD |
| Stock Based Compensation | 2,018,000USD |
| Change To Liabilities | -520,000USD |
| Change In Working Capital | 37,000USD |
| Operating Cash Flow | -8,408,000USD |
| Capital Expenditures | -74,000USD |
| Investing Cash Flow | -74,000USD |
| Financing Cash Flow | 35,388,000USD |
| Effect Of Forex Changes On Cash | -19,000USD |
| Change In Cash | 26,887,000USD |
| End Cash Flow | 57,164,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -5,311,000USD | -3,775,000USD | -4,230,000USD | -5,739,000USD | -8,654,000USD | -5,794,000USD | -7,000USD | 468,000USD |
| Depreciation | 24,000USD | 23,000USD | 28,000USD | 32,000USD | 33,000USD | 35,000USD | 35,000USD | 35,000USD |
| Stock Based Compensation | 930,000USD | 737,000USD | 401,000USD | 563,000USD | 621,000USD | 821,000USD | 1,005,000USD | 952,000USD |
| Other Non Cash Items | 937,000USD | 76,000USD | -112,000USD | -370,000USD | -63,000USD | -1,159,000USD | -6,871,000USD | -5,395,000USD |
| Change In Working Capital | 49,000USD | -194,000USD | -4,518,000USD | 2,501,000USD | -106,000USD | 2,798,000USD | -1,819,000USD | 4,670,000USD |
| Total Cash From Operating Activities | -4,301,000USD | -3,133,000USD | -8,431,000USD | -3,013,000USD | -8,169,000USD | -3,299,000USD | -7,657,000USD | 730,000USD |
| Capital Expenditures | -3,000USD | -44,000USD | 0USD | 0USD | -4,000USD | -4,000USD | 0USD | -62,000USD |
| Free Cash Flow | -4,304,000USD | -3,177,000USD | -8,431,000USD | -3,013,000USD | -8,173,000USD | -3,303,000USD | -7,657,000USD | 668,000USD |
| Investments | 0USD | 0USD | 0USD | 0USD | 4,496,000USD | 5,996,000USD | 12,000,000USD | -1,351,000USD |
| Total Cashflows From Investing Activities | -3,000USD | -32,000USD | — | — | 4,496,000USD | 5,996,000USD | 12,000,000USD | -1,351,000USD |
| Total Cash From Financing Activities | 35,346,000USD | 283,000USD | 30,069,000USD | -16,000USD | 91,000USD | 73,000USD | 0USD | 91,000USD |
| Issuance Of Capital Stock | 34,898,000USD | -28,230,000USD | 28,875,000USD | -16,000USD | 53,000USD | — | -91,000USD | 91,000USD |
| Change In Cash | 31,045,000USD | -2,843,000USD | 21,624,999USD | -3,007,000USD | -3,583,000USD | 2,637,000USD | 4,391,000USD | -511,000USD |
| Begin Period Cash Flow | 30,277,000USD | 33,120,000USD | 11,495,000USD | 14,502,000USD | 18,085,000USD | 15,448,000USD | 11,057,000USD | 11,568,000USD |
| End Period Cash Flow | 61,322,000USD | 30,277,000USD | 33,119,999USD | 11,495,000USD | 14,502,000USD | 18,085,000USD | 15,448,000USD | 11,057,000USD |
| Other Cashflows From Financing Activities | 35,346,000USD | 283,000USD | 30,069,000USD | — | 38,000USD | 73,000USD | 91,000USD | 91,000USD |
| Unclassified Financing Cash Flow | -34,898,000USD | 28,230,000USD | -28,875,000USD | — | — | — | — | — |
| Change To Account Receivables | — | 0USD | 0USD | 0USD | 0USD | 5,009,000USD | 885,000USD | -846,000USD |
| Other Cashflows From Investing Activities | — | 12,000USD | — | — | — | — | — | — |
| Net Borrowings | — | — | — | — | — | 0USD | 0USD | — |
| Sale Purchase Of Stock | — | — | — | — | — | 0USD | 91,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -22,398,000USD | -8,067,000USD | -13,335,000USD | -62,428,000USD | -39,052,000USD | -29,813,000USD | -25,600,000USD | -13,250,475USD |
| Depreciation | 116,000USD | 137,000USD | 126,000USD | 118,000USD | 72,000USD | 45,000USD | 23,000USD | 6,102USD |
| Stock Based Compensation | 2,322,000USD | 3,750,000USD | 3,997,000USD | 4,841,000USD | 4,410,000USD | 3,817,000USD | 2,252,000USD | 441,914USD |
| Other Non Cash Items | -469,000USD | -15,688,000USD | -10,025,000USD | 48,717,000USD | 237,000USD | 341,000USD | -337,000USD | 4,975,204USD |
| Change To Account Receivables | 0USD | 3,735,000USD | -897,000USD | -2,838,000USD | -2,838,000USD | -2,838,000USD | -2,838,000USD | — |
| Change In Working Capital | -2,317,000USD | 842,000USD | -2,546,000USD | 19,000USD | 1,698,000USD | 1,255,000USD | 713,000USD | 301,005USD |
| Total Cash From Operating Activities | -22,746,000USD | -19,026,000USD | -21,783,000USD | -8,733,000USD | -32,081,000USD | -24,624,000USD | -22,949,000USD | -7,526,250USD |
| Capital Expenditures | -48,000USD | -85,000USD | -50,000USD | -279,000USD | -57,000USD | -202,000USD | -74,000USD | -34,858USD |
| Free Cash Flow | -22,794,000USD | -19,111,000USD | -21,833,000USD | -9,012,000USD | -32,138,000USD | -24,826,000USD | -23,023,000USD | -7,561,108USD |
| Investments | 4,500,000USD | 13,814,000USD | 7,782,000USD | 18,684,000USD | 27,463,000USD | -18,592,000USD | -2,092,000USD | -37,399,471USD |
| Total Cashflows From Investing Activities | 4,464,000USD | 13,814,000USD | -4,762,000USD | 18,684,000USD | 27,406,000USD | -18,592,000USD | -2,166,000USD | -37,434,329USD |
| Total Cash From Financing Activities | 30,427,000USD | 164,000USD | -9,228,000USD | -1,215,000USD | 31,061,000USD | 53,945,000USD | 9,836,000USD | 66,365,560USD |
| Issuance Of Capital Stock | 682,000USD | 0USD | — | 0USD | 29,909,000USD | 53,782,000USD | 775,000USD | 64,475,457USD |
| Change In Cash | 12,192,000USD | -5,131,000USD | -35,891,000USD | 8,741,000USD | 26,384,000USD | 10,763,000USD | -15,289,000USD | 21,404,981USD |
| Begin Period Cash Flow | 18,085,000USD | 23,216,000USD | 59,107,000USD | 50,366,000USD | 23,982,000USD | 13,219,000USD | 28,508,000USD | 7,103,553USD |
| End Period Cash Flow | 30,277,000USD | 18,085,000USD | 23,216,000USD | 59,107,000USD | 50,366,000USD | 23,982,000USD | 13,219,000USD | 28,508,534USD |
| Other Cashflows From Investing Activities | 12,000USD | — | — | 700,000USD | — | — | -2,092,000USD | -37,399,470USD |
| Other Cashflows From Financing Activities | 30,427,000USD | 4,000USD | 165,000USD | 214,000USD | 1,152,000USD | 163,000USD | 111,000USD | 291,560USD |
| Net Borrowings | — | 0USD | -9,133,000USD | -1,429,000USD | -1,429,000USD | -1,429,000USD | 9,881,000USD | 1,599,012USD |
| Sale Purchase Of Stock | — | 160,000USD | -260,000USD | 0USD | 1,152,000USD | 53,945,000USD | -156,000USD | 64,475,457USD |
| Dividends Paid | — | — | -9,133,000USD | — | — | — | -9,881,000USD | — |
| Unclassified Investing Cash Flow | — | — | -12,494,000USD | — | — | — | 2,092,000USD | 37,399,470USD |
| Unclassified Financing Cash Flow | — | — | 9,133,000USD | — | 30,186,000USD | 1,266,000USD | 9,881,000USD | — |
| Change To Liabilities | — | — | — | 27,586,000USD | 1,521,000USD | 894,000USD | 1,826,000USD | 1,441,036USD |
| Cash And Cash Equivalents Changes | — | — | — | — | 26,386,000USD | 10,729,000USD | -15,279,000USD | 21,404,981USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2024Yearly · 2024-12-31 | Product | Research And Development Services | 28,300,000 | USD | 0001193125-26-124143 |
| FY 2024Yearly · 2024-12-31 | Product | Upfront Payment Amortization | 12,800,000 | USD | 0001193125-26-124143 |
| Q4 2024Quarterly · 2024-12-31 | Product | Research And Development Services | 3,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Upfront Payment Amortization | 1,300,000 | USD | Legacy provider |
| Q3 2024Quarterly · 2024-09-30 | Product | Research And Development Services | 8,100,000 | USD | 0001193125-25-280202 |
| Q3 2024Quarterly · 2024-09-30 | Product | Upfront Payment Amortization | 4,100,000 | USD | 0001193125-25-280202 |
| Q2 2024Quarterly · 2024-06-30 | Product | Other | 3,353,000 | USD | 0000950170-24-093949 |
| Q2 2024Quarterly · 2024-06-30 | Product | Research And Development Services | 9,200,000 | USD | 0000950170-24-093949 |
| Q2 2024Quarterly · 2024-06-30 | Product | Upfront Payment Amortization | 1,300,000 | USD | 0000950170-24-093949 |
| Q1 2024Quarterly · 2024-03-31 | Product | Research And Development Services | 8,000,000 | USD | 0000950170-25-071389 |
| Q1 2024Quarterly · 2024-03-31 | Product | Upfront Payment Amortization | 2,700,000 | USD | 0000950170-25-071389 |
| FY 2023Yearly · 2023-12-31 | Product | Research And Development Services | 27,000,000 | USD | 0000950170-25-045726 |
| FY 2023Yearly · 2023-12-31 | Product | Upfront Payment Amortization | 9,100,000 | USD | 0000950170-25-045726 |
| Q4 2023Quarterly · 2023-12-31 | Product | Research And Development Services | 6,800,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Product | Upfront Payment Amortization | 2,400,000 | USD | Legacy provider |
| Q3 2023Quarterly · 2023-09-30 | Product | Research And Development Services | 6,700,000 | USD | 0000950170-23-061108 |
| Q3 2023Quarterly · 2023-09-30 | Product | Upfront Payment Amortization | 2,200,000 | USD | 0000950170-23-061108 |
| Q2 2023Quarterly · 2023-06-30 | Product | Research And Development Services | 6,800,000 | USD | 0000950170-23-040583 |
| Q2 2023Quarterly · 2023-06-30 | Product | Upfront Payment Amortization | 2,300,000 | USD | 0000950170-23-040583 |
| Q1 2023Quarterly · 2023-03-31 | Product | Research And Development Services | 6,700,000 | USD | 0000950170-24-056960 |
| Q1 2023Quarterly · 2023-03-31 | Product | Upfront Payment Amortization | 2,200,000 | USD | 0000950170-24-056960 |
| FY 2022Yearly · 2022-12-31 | Product | Research And Development Services | 11,800,000 | USD | 0000950170-24-035919 |
| FY 2022Yearly · 2022-12-31 | Product | Upfront Payment Amortization | 4,000,000 | USD | 0000950170-24-035919 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.